BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Verhulst E, Garnier D, De Meester I, Bauvois B. Validating Cell Surface Proteases as Drug Targets for Cancer Therapy: What Do We Know, and Where Do We Go? Cancers (Basel) 2022;14:624. [PMID: 35158891 DOI: 10.3390/cancers14030624] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang Z, Wang J, Lan T, Zhang L, Yan Z, Zhang N, Xu Y, Tao Q. Role and mechanism of fibroblast-activated protein-α expression on the surface of fibroblast-like synoviocytes in rheumatoid arthritis. Front Immunol 2023;14. [DOI: 10.3389/fimmu.2023.1135384] [Reference Citation Analysis]
2 Peng S, Yuan X, Li H, Wei Y, Zhou B, Ding G, Bai J. Recent progress in nanocarrier-based drug delivery systems for antitumour metastasis. Eur J Med Chem 2023;252:115259. [PMID: 36934485 DOI: 10.1016/j.ejmech.2023.115259] [Reference Citation Analysis]
3 Tannoury M, Garnier D, Susin SA, Bauvois B. Current Status of Novel Agents for the Treatment of B Cell Malignancies: What's Coming Next? Cancers (Basel) 2022;14. [PMID: 36551511 DOI: 10.3390/cancers14246026] [Reference Citation Analysis]
4 Wang K, Xuan Z, Liu X, Zheng M, Yang C, Wang H. Immunomodulatory role of metalloproteinase ADAM17 in tumor development. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1059376] [Reference Citation Analysis]
5 Jovanović M, Stanković T, Stojković Burić S, Banković J, Dinić J, Ljujić M, Pešić M, Dragoj M. Decreased TSPAN14 Expression Contributes to NSCLC Progression. Life 2022;12:1291. [DOI: 10.3390/life12091291] [Reference Citation Analysis]